Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07SWU
|
|||
| Former ID |
DCL000250
|
|||
| Drug Name |
TM30338
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Discontinued in Phase 2 | [1] | |
| Company |
7TMPharma.
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Neuropeptide Y receptor type 2 (NPY2R) | Target Info | Modulator | [2] |
| Neuropeptide Y receptor type 4 (NPY4R) | Target Info | Modulator | [2] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Peptide ligand-binding receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Peptide GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023122) | |||
| REF 2 | Anti-Obesity Drug Discovery and Development, Atta-ur- Rahman, page(108) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.